These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 15950748)

  • 21. Synthesis of 2',3'-dideoxynucleoside 5'-alpha-P-borano-beta,gamma-(difluoromethylene)triphosphates and their inhibition of HIV-1 reverse transcriptase.
    Boyle NA; Rajwanshi VK; Prhavc M; Wang G; Fagan P; Chen F; Ewing GJ; Brooks JL; Hurd T; Leeds JM; Bruice TW; Cook PD
    J Med Chem; 2005 Apr; 48(7):2695-700. PubMed ID: 15801860
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Gln151 of HIV-1 reverse transcriptase acts as a steric gate towards clinically relevant acyclic phosphonate nucleotide analogues.
    Frangeul A; Bussetta C; Deval J; Barral K; Alvarez K; Canard B
    Antivir Ther; 2008; 13(1):115-24. PubMed ID: 18389906
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The G490E mutation in reverse transcriptase does not impact tRNA primer selection by HIV-1 with altered PBS and A-loop.
    Xu W; Morrow CD
    Virology; 2006 Sep; 352(2):380-9. PubMed ID: 16781756
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The molecular basis of inhibition and toxicity of modified cytosine analogues targetting HIV-1 reverse transcriptase.
    Anderson KS
    Antivir Chem Chemother; 2001; 12 Suppl 1():13-7. PubMed ID: 11594679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo.
    Martinez-Picado J; Martínez MA
    Virus Res; 2008 Jun; 134(1-2):104-23. PubMed ID: 18289713
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of resistance to nucleoside analogue inhibitors of HIV-1 reverse transcriptase.
    Menéndez-Arias L
    Virus Res; 2008 Jun; 134(1-2):124-46. PubMed ID: 18272247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of the translocation status of human immunodeficiency virus type 1 reverse transcriptase on the efficiency of excision of tenofovir.
    Marchand B; White KL; Ly JK; Margot NA; Wang R; McDermott M; Miller MD; Götte M
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2911-9. PubMed ID: 17517852
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel nonnucleoside inhibitors that select nucleoside inhibitor resistance mutations in human immunodeficiency virus type 1 reverse transcriptase.
    Zhang Z; Walker M; Xu W; Shim JH; Girardet JL; Hamatake RK; Hong Z
    Antimicrob Agents Chemother; 2006 Aug; 50(8):2772-81. PubMed ID: 16870771
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insights into the Molecular Mechanism of Polymerization and Nucleoside Reverse Transcriptase Inhibitor Incorporation by Human PrimPol.
    Mislak AC; Anderson KS
    Antimicrob Agents Chemother; 2016 Jan; 60(1):561-9. PubMed ID: 26552983
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitochondrial DNA base excision repair and mitochondrial DNA mutation in human hepatic HuH-7 cells exposed to stavudine.
    Wu Y; Li N; Zhang T; Wu H; Huang C; Chen D
    Mutat Res; 2009 May; 664(1-2):28-38. PubMed ID: 19428378
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Probing the mechanistic consequences of 5-fluorine substitution on cytidine nucleotide analogue incorporation by HIV-1 reverse transcriptase.
    Ray AS; Schinazi RF; Murakami E; Basavapathruni A; Shi J; Zorca SM; Chu CK; Anderson KS
    Antivir Chem Chemother; 2003 May; 14(3):115-25. PubMed ID: 14521328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Indolopyridones inhibit human immunodeficiency virus reverse transcriptase with a novel mechanism of action.
    Jochmans D; Deval J; Kesteleyn B; Van Marck H; Bettens E; De Baere I; Dehertogh P; Ivens T; Van Ginderen M; Van Schoubroeck B; Ehteshami M; Wigerinck P; Götte M; Hertogs K
    J Virol; 2006 Dec; 80(24):12283-92. PubMed ID: 17020946
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural determinants in human DNA polymerase gamma account for mitochondrial toxicity from nucleoside analogs.
    Lim SE; Ponamarev MV; Longley MJ; Copeland WC
    J Mol Biol; 2003 May; 329(1):45-57. PubMed ID: 12742017
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insight into the mechanism of a peptide inhibitor of HIV reverse transcriptase dimerization.
    Depollier J; Hourdou ML; Aldrian-Herrada G; Rothwell P; Restle T; Divita G
    Biochemistry; 2005 Feb; 44(6):1909-18. PubMed ID: 15697216
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel HIV-1 reverse transcriptase inhibitors.
    Jochmans D
    Virus Res; 2008 Jun; 134(1-2):171-85. PubMed ID: 18308412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro selection of mutations in human immunodeficiency virus type 1 reverse transcriptase that confer resistance to capravirine, a novel nonnucleoside reverse transcriptase inhibitor.
    Sato A; Hammond J; Alexander TN; Graham JP; Binford S; Sugita K; Sugimoto H; Fujiwara T; Patick AK
    Antiviral Res; 2006 Jun; 70(2):66-74. PubMed ID: 16472877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The nucleoside analogs 4'C-methyl thymidine and 4'C-ethyl thymidine block DNA synthesis by wild-type HIV-1 RT and excision proficient NRTI resistant RT variants.
    Boyer PL; Julias JG; Ambrose Z; Siddiqui MA; Marquez VE; Hughes SH
    J Mol Biol; 2007 Aug; 371(4):873-82. PubMed ID: 17597154
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stepping statistics of single HIV-1 reverse transcriptase molecules during DNA polymerization.
    Ortiz TP; Marshall JA; Meyer LA; Davis RW; Macosko JC; Hatch J; Keller DJ; Brozik JA
    J Phys Chem B; 2005 Aug; 109(33):16127-31. PubMed ID: 16853049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mutagenesis of Gln294 of the reverse transcriptase of human immunodeficiency virus type-2 and its effects on the ribonuclease H activity.
    Bochner R; Duvshani A; Adir N; Hizi A
    FEBS Lett; 2008 Aug; 582(18):2799-805. PubMed ID: 18625228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations that abrogate human immunodeficiency virus type 1 reverse transcriptase dimerization affect maturation of the reverse transcriptase heterodimer.
    Wapling J; Moore KL; Sonza S; Mak J; Tachedjian G
    J Virol; 2005 Aug; 79(16):10247-57. PubMed ID: 16051818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.